Strutture
Servizi
Contenuto della pagina - Torna all'inizio
 | Cazzola MarioProfessore Ordinario Sede: Ematologia IRCCS Fondazione San Matteo Viale Golgi 19 - 27100 Pavia Link:  |
| Telefono | +39 382 503595 0382-526263 |
| Fax | 0382-502250 |
| mario.cazzola@unipv.it | |
| Orari di ricevimento | 0382-527857 (segreteria universitaria) |
| Insegnamenti | Insegnamenti: Malattie del sangue (Corso Golgi) Blood diseases (Harvey course) |
| Curriculum | CV Cazzola |
| Pubblicazioni | Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005 Apr 28;352(17):1779-90. PubMed PMID: 15858187. Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol. 2005 Oct 20;23(30):7594-603. Epub 2005 Sep 26. PubMed PMID: 16186598. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007 Aug 10;25(23):3503-10. PubMed PMID: 17687155. Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D, Pellagatti A, Wainscoat JS, Hellstrom-Lindberg E, Gambacorti-Passerini C, Godfrey AL, Rapado I, Cvejic A, Rance R, McGee C, Ellis P, Mudie LJ, Stephens PJ, McLaren S, Massie CE, Tarpey PS, Varela I, Nik-Zainal S, Davies HR, Shlien A, Jones D, Raine K, Hinton J, Butler AP, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011 Oct 13;365(15):1384-95. Epub 2011 Sep 26. PubMed PMID: Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C, Travaglino E, Groves MJ, Godfrey AL, Ambaglio I, Gallì A, Da Vià MC, Conte S, Tauro S, Keenan N, Hyslop A, Hinton J, Mudie LJ, Wainscoat JS, Futreal PA, Stratton MR, Campbell PJ, Hellström-Lindberg E, Cazzola M. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011 Dec 8;118(24):6239-46. Epub 2011 Oct 12. PubMed PMID: 21998214. |
| Collaborazioni | Karolinska Institutet, Stoccolma Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, Oxford Sanger Institute, Cancer Genome Project, Cambridge Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna |